自拍偷区亚洲及综合第一页,亚洲av无码潮喷在线观看,最近2019中文字幕一页二页,最近中文字幕高清字幕mv,中文字幕无码人妻少妇免费

訂購信息
上海拜力生物科技公司
Tel:400-968-7988    021-33779008
Anti-FBN1 (N2843) Antibody
品牌:Antibodies
貨號:
規(guī)格:50μl
貨期:
應(yīng)用: 點(diǎn)擊這里給我發(fā)消息  咨詢客服

Anti-FBN1 (N2843) Antibody

商品詳情 參考文獻(xiàn) 相關(guān)資料
Name: Anti-FBN1 (N2843) Antibody
See all FBN1 primary antibodies
Description: Rabbit polyclonal antibody to FBN1 (N2843)
Specificity: Fibrillin-1 (N2843) pAb detects endogenous levels of Fibrillin-1 protein.
Applications: WB, IHC
Reactivity: Human, Mouse, Rat
Immunogen: Synthetic peptide, corresponding to amino acids C-terminus of Human FBN1.
Host: Rabbit
Clonality: Polyclonal
Conjugate: Unconjugated
Molecular Weight: ~ 312 kDa
Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Product Form: 1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2.
Function: Fibrillin-1: Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:1860873, PubMed:15062093). Fibrillin-1-containing microfibrils provide long-term force bearing structural support. In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin. In addition, microfibrils can occur as elastin-independent networks in tissues such as the ciliary zonule, tendon, cornea and glomerulus where they provide tensile strength and have anchoring roles. Fibrillin-1 also plays a key role in tissue homeostasis through specific interactions with growth factors, such as the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs) and latent transforming growth factor-beta-binding proteins (LTBPs), cell-surface integrins and other extracellular matrix protein and proteoglycan components (PubMed:27026396). Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively (By similarity). Negatively regulates osteoclastogenesis by binding and sequestering an osteoclast differentiation and activation factor TNFSF11. This leads to disruption of TNFSF11-induced Ca2+ signaling and impairment of TNFSF11-mediated nuclear translocation and activation of transcription factor NFATC1 which regulates genes important for osteoclast differentiation and function (PubMed:24039232). Mediates cell adhesion via its binding to cell surface receptors integrins ITGAV:ITGB3 and ITGA5:ITGB1 (PubMed:12807887, PubMed:17158881). Binds heparin and this interaction has an important role in the assembly of microfibrils (PubMed:11461921).
Involvement in Disease: Marfan syndrome: A hereditary disorder of connective tissue that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with Marfan syndrome, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in most of the patients and is almost always bilateral. The leading cause of premature death is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Neonatal Marfan syndrome is the most severe form resulting in death from cardiorespiratory failure in the first few years of life.

Ectopia lentis 1, isolated, autosomal dominant: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation.

Weill-Marchesani syndrome 2: A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma.

Overlap connective tissue disease: Heritable disorder of connective tissue characterized by involvement of the mitral valve, aorta, skeleton, and skin. MASS syndrome is closely resembling both the Marfan syndrome and the Barlow syndrome. However, no dislocation of the lenses or aneurysmal changes occur in the aorta, and the mitral valve prolapse is by no means invariable.

Stiff skin syndrome: A syndrome characterized by hard, thick skin, usually over the entire body, which limits joint mobility and causes flexion contractures. Other occasional findings include lipodystrophy and muscle weakness.

Geleophysic dysplasia 2: An autosomal dominant disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues.

Acromicric dysplasia: An autosomal dominant disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have distinct facial features, including round face, well-defined eyebrows, long eyelashes, bulbous nose with anteverted nostrils, long and prominent philtrum, and thick lips with a small mouth. Other characteristic features include hoarse voice and pseudomuscular build, and there are distinct skeletal features as well, including an internal notch of the femoral head, internal notch of the second metacarpal, and external notch of the fifth metacarpal.

Marfan lipodystrophy syndrome: A syndrome characterized by congenital lipodystrophy, a progeroid facial appearance due to lack of subcutaneous fat, and variable signs of Marfan syndrome. Clinical features include premature birth with an accelerated linear growth disproportionate to the weight gain, ectopia lentis, aortic dilatation, dural ectasia, and arachnodactyly. Mental and motor development are within normal limits.
Sequence Similarities: Belongs to the fibrillin family.
Post-Translational Modification: Fibrillin-1: Cleavage of N- and C-terminus by furin is required for incorporation into the extracellular matrix and assembly into microfibrils (PubMed:27026396). The C-terminus, which corresponds to the Asprosin chain, was initially thought to constitute a propeptide (PubMed:24982166). Fibrillin-1 and Asprosin chains are still linked together during the secretion from cells, but are subsequently separated by furin, an essential step for incorporation of Fibrillin-1 into the nascent microfibrils (PubMed:24982166).
Cellular Location: Secreted.

Fibrillin-1 and Asprosin chains are still linked together during the secretion from cells, but are subsequently separated by furin (PubMed:24982166).
Database Links:
  • Entrez Gene: 2200?Human
  • Entrez Gene: 83727?Rat
  • Omim: 134797?Human
  • SwissProt: P35555?Human
  • SwissProt: Q61554?Mouse
  • Unigene: 591133?Human
  • Unigene: 271644?Mouse
  • Unigene: 12759?Rat
  • Synonyms:
  • 350 kDa glycoprotein component extracellular microfibril Antibody
  • ACMICD Antibody
  • FBN Antibody
  • FBN 1 Antibody
  • FBN1 Antibody
  • FBN1_HUMAN Antibody
  • Fibrillin 1 Antibody
  • Fibrillin 15 Antibody
  • Fibrillin-1 Antibody
  • Fibrillin1 Antibody
  • Fibrillin15 Antibody
  • GPHYSD2 Antibody
  • Marfan syndrome Antibody
  • MASS Antibody
  • MFS 1 Antibody
  • MFS1 Antibody
  • OCTD Antibody
  • SGS Antibody
  • SSKS Antibody
  • Weill Marchesani syndrome Antibody
  • WMS Antibody
  • WMS2 Antibody
  • Information: Target information shown above is from the UniProt Consortium.
    熱銷產(chǎn)品
    熱銷產(chǎn)品排行榜
    • 關(guān)于我們
    • 購物流程
    • 支付方式
    • 配送方式

    請打開QQ掃碼聯(lián)系
    Copyright@ 2003-2025  進(jìn)口試劑采購網(wǎng)版權(quán)所有     

    BIOLEAF熱搜   BIOLEAF試劑盒   BIOLEAF ELISA   BIOLEAF試劑   BIOLEAF品牌   BIOLEAF抗體   BIOLEAF耗材   BIOLEAF小儀器

    sitemap   細(xì)胞庫查詢   危險品圖標(biāo)

    本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!

             滬ICP備08023583號-6     
    產(chǎn)品咨詢
    QQ掃碼溝通
    在線客服
    服務(wù)電話
    400-968-7988
    掃碼關(guān)注
    微信公眾號二維碼

    滬公網(wǎng)安備 31011202007338號